REG - HeiQ PLC - Director/PDMR Dealing

HeiqAnnouncement

04/12/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231204:nRSD4658Va&default-theme=true

RNS Number : 4658V  HeiQ PLC  04 December 2023

4 December 2023

 

HeiQ Plc

("HeiQ" or "the Company")

Director / PDMR Dealing

HeiQ Plc (LSE: HEIQ), a leading company in materials innovation and hygiene
technologies, has been notified that on 1 December 2023, Karen Brade,
Non-Executive Director, purchased 32,287 ordinary shares in the Company
("Ordinary Shares") at a price of 15.372 pence per share.

Following the purchase, Mrs. Brade holds an interest in 40,263 Ordinary
Shares. The total interest held by Mrs. Brade represents approximately 0.03
per cent of the Company's issued ordinary share capital.

This announcement, including the notification below, is made in accordance
with the requirements of the UK Market Abuse Regulation.

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Karen Brade

 2    Reason for the notification

 a)   Position/status                                              Non-Executive Director

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         HeiQ plc

 b)   LEI                                                          213800IGT65IMJDO4S03

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary Shares of 30 pence each

      Identification code

                                                                   GB00BN2CJ299

 b)   Nature of the transaction                                    Purchase of Ordinary Shares

 c)   Price(s) and volume(s)

Price(s)      Volume(s)

                                                                   15.372 pence  32,287

 

 d)   Aggregated information                                       N/A

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      1 December 2023

 f)   Place of the transaction                                     London Stock Exchange, Main Market

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

e)

 

Date of the transaction

 

 

1 December 2023

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market

 

 For further information, please contact:

 HeiQ Plc                                          +41 56 250 68 50

 Carlo Centonze (CEO)
 Cenkos Securities plc (Joint Broker)              +44 (0) 207 397 8900

 Stephen Keys / Callum Davidson
 SEC Newgate (Media Enquiries)                     +44 (0) 20 3757 6882

 Elisabeth Cowell / Tom Carnegie / Molly Gretton   HeiQ@s (mailto:HeiQ@secnewgate.co.uk) ecnewgate (mailto:HeiQ@secnewgate.co.uk)
                                                   .co.uk (mailto:HeiQ@secnewgate.co.uk)

 

About HeiQ

HeiQ is a Swiss-based international company that innovates pioneering and
differentiating materials in partnership with established global brands. We
bridge the academic and commercial worlds to conceive performance-enhancing
materials and technologies, working with aligned brands to research,
manufacture and bring products to market, aiming for lab to consumer in
months. Our goal is to improve the lives of billions by innovating the
materials that go into everyday products, making them more hygienic,
comfortable, protective, and sustainable.

Our strong IP portfolio positions us as an innovation leader for niche,
premium and high-margin products in the textile chemicals, man-made fibers,
paints and coatings, antimicrobial plastics, probiotics and household cleaner
markets. We have also expanded into healthcare facilities, probiotic cleaning,
and hygiene coatings markets to help make hospitals and healthcare
environments more hygienic.

We have developed over 200 technologies in partnership with 300 major brands.
With a substantial research and development pipeline, including key technology
development projects HeiQ AeoniQ, HeiQ ECOS, HeiQ GrapheneX, and HeiQ Synbio,
HeiQ aims to deliver shareholder value through sales growth and entry into new
lucrative markets through disruptive innovation and M&A.

We have built a strong reputation for ESG & sustainable innovation, having
won multiple awards including the Swiss Technology Award twice and the Swiss
Environmental Award. Under experienced leadership, we are committed to driving
our profit in close connection with people and the planet. For more
information, please visit www.heiq.com (http://www.heiq.com/) .

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHEAXAFEFSDFFA